Skip to content

A study to evaluate the efficacy of pectoral nerve block ie to make pectoral nerve numb, as a pain killer in breast cancer patients after their surgery.

Randomized controlled study to evaluate the efficacy of pectoral nerve block for post operative analgesia in patients undergoing mastectomy.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/04/008289
Enrollment
60
Registered
2017-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA I/ ASA II patients posted for unilateral non-reconstructive mastectomy

Interventions

Intervention1: PEC group: This group will receive ipsilateral Pectoral nerve block I & II under ultra sonographic guidance by experienced anaesthesiologist Control Intervention1: CONTROL group: This g

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA I/ ASA II patients 2. Posted for unilateral non-reconstructivemastectomy. 3. Informed consent

Exclusion criteria

Exclusion criteria: 1. Sensitivity to local anaesthetic agent. 2. Bleeding disorders or receiving anticoagulants. 3. Body mass index (BMI) > 35/kg/m2. 4. Pregnancy. 5. Post radiation patients. 6. Patients on other studies which can interfere with the outcome of the study. 7. Patients with deranged liver function test and renal function test.

Design outcomes

Primary

MeasureTime frame
1. Immediate post operative pain scores at rest and movement after shifting the patient to recovery and then 2 hourly till 6 hours 2. Time to rescue analgesia.Timepoint: Post operative pain scores at rest and movement after shifting the patient to recovery and then at 2hrs, 4 hrs and 6 hrs.

Secondary

MeasureTime frame
1. Total intraoperative fentanyl consumption 2. Postoperative pain scores at 12, 18 and 24 hours or at discharge whichever is earlier. 3. Post operative nausea vomiting. 4. Patient satisfaction. 5. Complications, if any. Timepoint: Postoperative 12, 18 and 24 hours

Countries

India

Contacts

Public ContactDr Sudivya Sharma

Tata Memorial Hospital

drsudivyasharma@gmail.com9892762615

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 24, 2026